Grifols

Summary

Grifols appeared to be the Corporate Investor, which was created in 1940. The main office of represented Corporate Investor is situated in the Barcelona. The company was established in Europe in Spain.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Celyad, GigaGen

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Grifols, startups are often financed by Prolog Ventures, OrbiMed, Fisk Ventures. The meaningful sponsors for the fund in investment in the same round are Hunza Ventures, Life Sciences Research Partners V.Z.W.. In the next rounds fund is usually obtained by Perceptive Advisors, Hunza Ventures.

The typical startup value when the investment from Grifols is 10-50 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Grifols works on 9 percentage points less the average amount of lead investments. Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2009. The higher amount of exits for fund were in 2015.